Pierre Fabre use of in vitro ocular irritancy test shows 87% concordance with Draize test.
This article was originally published in The Rose Sheet
Executive Summary
PIERRE FABRE ANALYSIS OF IN VITRO OCULAR IRRITANCY TEST SHOWS 87% DRAIZE CONCORDANCE in an in vitro/animal test correlation study, Pierre Fabre Dermatology and Cosmetology Project Director Patrick Dupuy, MD, said at International Business Communications' Novel In Vitro and Clinical Testing Methods for Skin Care and Cosmetics Products conference held Sept. 17-18 in Boston. Pierre Fabre used Rennes, France-based Biopredic's Predisafe ocular irritancy test in the correlation analysis because it is the "most relevant" and "cost effective" method among in vitro ocular irritancy assays, Dupuy said.